Artivion appoints Elizabeth Hoff to Board of Directors effective Oct 1, 2022

ARTIVION, INC.

Board expanded to nine directors; Hoff appointed to Compliance Committee.
Hoff brings 30+ years medical device experience including aortic space at Guidant, W.L. Gore, Medtronic.
Board determined Hoff qualifies as independent under NYSE standards.
Hoff will receive same equity and cash compensation as other non-employee directors per April 2022 proxy.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Elizabeth A. Hoff

director

AORT · ARTIVION, INC.

Effective: 2022-10-01
Filed: September 29, 2022, 7:59 PM ET

increased the size of the Board to nine directors and appointed Elizabeth A. Hoff as a director and a member of the Compliance Committee of the Board, effective October 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Elizabeth A. Hoff was appointed as director at ARTIVION, INC..

Action: appointed
Role: director

Exact text from the filing

increased the size of the Board to nine directors and appointed Elizabeth A. Hoff as a director and a member of the Compliance Committee of the Board, effective October 1, 2022.

View on SEC.gov

ARTIVION, INC. filing history →

Source: SEC EDGAR

accession 0000784199-22-000174

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.